Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...
Concerns arise as Medisep 2 excludes essential eye treatment for age-related macular degeneration, risking vision for Kerala’s pensioners.
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So it works quite well as a VEGFR inhibitor and it is de-risked in that sense.
Pakistan Tehreek-e-Insaf founder Imran Khan was transferred from Adiala jail to the Pakistan Institute of Medical Sciences ...
A significant expansion of advanced medical services in the north: New clinics, advanced tests, and greater accessibility for ...
Micah is a happy little boy who can now see the world around him, thanks to specialists at the Alberta Children’s Hospital. After experiencing two losses, at 18 weeks and 21 weeks, Tamlyn and Steve ...
Latest treatments for Age-related Macular Degeneration (AMD) are giving hope to thousands of people living with the condition.
Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript February 3, 2026 Merck & Co., Inc. beats earnings expectations.
From filters and coatings to tints and dyes, here's how brands are continuously innovating your eyewear ...
The Brighterside of News on MSN
FDA-approved diabetes drug could treat common cause of blindness
Doctors are finding new hope for people at risk of losing their sight from age-related macular degeneration, or AMD. Research from the University of Liverpool suggests that metformin, a long-used ...
Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...
High blood pressure can silently damage the eyes and lead to vision loss. Experts explain early signs, risks, and how regular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results